You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. STTR Phase I:Effect of Alcohol Concentration on Lactic to Acrylic Selectivity and Deactivation Rate over Na-FAU Zeolite Catalysts

    SBC: LAKRIL TECHNOLOGIES CORPORATION            Topic: CT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to commercialize a process to produce low carbon, bio-based acrylic acid and acrylates for paints, coatings, adhesives, and superabsorbent polymer markets. This $10 billion market has been seeking a bio-based, low-carbon alternative for decades, with economics serving as the major barrier. ...

    STTR Phase I 2023 National Science Foundation
  2. STTR Phase I: Transfer Training Device to Reduce Falls and Increase Mobility in Older Adults

    SBC: TERRY VENTURES, LLC            Topic: MD

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is a novel walker with active corrective feedback and training protocols enabling patients the ability to reliably and repeatedly transition from a seated position to a standing posture. Falls among elderly adults are the leading cause of injury resulting in 3 million emergency room visits and ...

    STTR Phase I 2023 National Science Foundation
  3. STTR Phase I:Refrigerant Ionic liquid Separation

    SBC: ICONIUM ENGINEERING COMPANY            Topic: CT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project will be to provide the refrigerant industry with the first commercial designs for separating complex, multi-component, azeotropic refrigerant mixtures for economical recycling. The American Innovation and Manufacturing Act authorizes the Environmental Protection Agency (EPA) to phase down prod ...

    STTR Phase I 2023 National Science Foundation
  4. STTR Phase I: Machine Learning-Based Smart Data Compression Solutions for Structural Health Monitoring Sensors

    SBC: ZQAI LLC            Topic: I

    The broader impact/commercial impact of this Small Business Technology Transfer (STTR) Phase I project is to enable efficient monitoring of civil infrastructures and rapid decision-making on their structural safety. The conditions of aging structures are monitored using structural health monitoring (SHM) sensors. These sensors produce very large datasets.In this project, a data compression solutio ...

    STTR Phase I 2023 National Science Foundation
  5. STTR Phase II:Stem Cell Delivery in Microscopic Hydrogel Droplets for Faster and More Complete Healing of Equine Tendon and Ligament Injuries

    SBC: CellDrop Inc            Topic: PT

    The broader impact of this Small Business Technology Transfer (STTR) Phase II project involves continued development of technology to extend the therapeutic window of cell-based tissue regeneration therapies. This technology could significantly enhance the scientific understanding of cellular therapies and enable the healing of injuries more rapidly and less invasively than current techniques. A s ...

    STTR Phase II 2023 National Science Foundation
  6. Clinical biomarker for early prediction of chemotherapy-induced peripheral neuropathy

    SBC: NEWVENTUREIQ LLC            Topic: 102

    Project Summary / Abstract Chemotherapy induced peripheral neuropathy (CIPN) is a major side effect of oxaliplatin, a key drug in 1st line regimens for treating colorectal cancer. Dose-limiting CIPN prevents rt25% of patients from receiving full, maximally effective dose of oxaliplatin. In addition, 10-40% of patients receiving oxaliplatin-based therapy for colorectal cancer with develop chronic C ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  7. Automating Assessment of Contextualization of Care During the Clinical Encounter

    SBC: Institute for Practice and Provider Performance Improvement, Inc.            Topic: 600

    Background: Large scale studies have demonstrated that when patients struggle with life challenges that complicate their care (e.g., a lack of social support, competing responsibilities, or financial hardships), health care providers can improve health care outcomes and lower costs if they attempt to identify these “contextual factors” and address them in their care plan – a process termed ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  8. Motion-Resistant Background Subtraction Angiography with Deep Learning:Real-Time, Edge Hardware Implementation and Product Development

    SBC: CLEARVOYA LLC            Topic: NHLBI

    Catheter Digital Subtraction Angiography (DSA) is an imaging technique that was developed in the 1980s to allow physicians to visualize blood vessels. Today, this technology is utilized for minimally-invasive interventions that treat numerous devastating pathologies, including stroke and myocardial infarction, diseases that disproportionally impact underserved minority patient populations.Catheter ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  9. A novel, non-antibiotic, microbiome-directed agent to prevent post-surgical infection

    SBC: Covira Surgical            Topic: NIAID

    SUMMARY Covira Surgical, Inc. is developing CS-0003, a first-in-class, orally administered non-antibiotic therapy for preventing infections in patients undergoing gastrointestinal (GI) surgeries. Despite improved surgical procedures, broad use of antibiotics, mandated asepsis measures, and enhanced recovery programs, post-surgical infections remain a clear and present danger to patients. Surgical ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. SMALL MOLECULE THERAPEUTIC FOR ALZHEIMER'S DISEASE

    SBC: SOMATOLYNK, INC.            Topic: NIA

    An estimated one out of eight individuals over the age of 65 has Alzheimer’s disease (AD), with a prevalence of 1-in-3 for those over age 85. There are approximately 5.8 million people in the USA with AD, with a global projection of over 150 million by 2050. There remains a lack of effective treatment to halt disease progression. Somatostatin receptor-4 (SSTR4) represents an innovative and viabl ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government